Trial
NCT02271347
An Open-Label, Multicenter Study of the Safety and Anti Viral Activity of Brincidofovir (BCV, CMX001) for Ebola Virus Disease
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Jazz Pharmaceuticals
Collaborators
—
Condition
Ebola Virus
Intervention
CMX001
Why stopped
Suspended Development Program
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-02-02